Suppression of experimental allergic encephalomyelitis in the Lewis rat, by administration of an acylated synthetic peptide of myelin basic protein

Journal of Neuroimmunology

Volumn 73, Issue 1-2, 1997, Pages 90-100

  St Louis, Joanne ^a   Chan, Edwin L ^a   Singh, Bhagirath ^a   Strejan, Gill H ^a  

^a Health Sciences Centre   (Canada)

Author keywords

anergy; experimental allergic encephalomyelitis; MBP peptides; treatment

Indexed keywords

INTERLEUKIN 2; LIPOSOME; MYELIN BASIC PROTEIN; SYNTHETIC PEPTIDE;

ACETYLATION; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ETIOLOGY; HISTOLOGY; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ACYLATION; AMINO ACID SEQUENCE; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INJECTIONS, INTRAVENOUS; LIPOSOMES; LYMPHOCYTE TRANSFUSION; LYMPHOCYTES; MALE; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW;

EID: 0343196673     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00174-9     Document Type: Article

References (44)

1. Alvord, E.J., Shaw, C.M., Hruby, S. and Kies, M. (1965) Encephalitogen-induced inhibition of Experimental Allergic Encephalomyelitis: prevention, suppression and therapy. Ann. N.Y. Acad. Sci. 122, 333-345.
2. Ando, D.G., Clayton, J., Kono, D., Urban, J.L. and Sercarz, E.E. (1989) Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomelitis (EAE) are th Th-1 lymphokine subtype. Cell. Immunol. 124, 132-143.
3. Avrilionis, K. and Boggs, J.M. (1991) Suppression of experimental allergic encephalomyelitis by the encephalitogenic peptide in solution or bound to liposomes. J. Neuroimmunol. 35, 201-210.
4. Baron, J.L., Madri, J.A., Ruddle, N.H., Hashim, G. and Janeway, Jr., C.A. (1993) Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177, 57-68.
5. Ben-Nun, A. and Cohen, I.R. (1982) Experimental Autoimmune Encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. J. Immunol. 129, 303-308.
6. Boggs, J.M., Goundalkar, A., Doganoglu, F., Samji, N., Kurantsin-Mills, J. and Koshy, K.M. (1987) Antigen-targeted liposome-encapsulated methotrexate specifically kills lymphocyte sensitized to the nonapeptide of myelin basic protien. J. Neuroimmunol. 17, 35-48.
7. Boyer, M., Novak, Z., Fraga, E., Oikawa, K., Kay, C.M., Fotedar, A. and Singh, B. (1990) Functional degeneracy of residues in a T cell peptide epitope contributes to its recognition by different T cell hybridomas. Int. Immunol. 2, 1221-1233.
8. Critchfield, J.M., Racke, M.K., Zuniga-Pflucker, J.C., Cannella, B., Raine, C.S., Goverman, J. and Lenardo, M.J. (1994) T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science, 263, 1139-1143.
9. Deibler, G.E., Martenson, R.E. and Kies, M.W. (1972) Large scale preparation of myelin basic protien from central nervous tissue of several mammalian species. Prep. Biochem. 2, 139-165.
10. Gaur, A., Wiers, B., Liu, A., Rothbard, J. and Fathman, C.G. (1992) Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258, 1491-1494.
11. Heber-Katz, E., Watari, E. and Dietzschold, B. (1988) Pathways to presentation. In: B. Pernis, S.C. Silverstein and H.J. Vogel (Eds.), Processing and Presentation of Antigens, Academic Press, San Diego, pp. 133-141.
12. Holda, J. and Swanborg, R.H. (1982) Autoimmune effector cells. II. Transfer of experimental Encephalomyelitis with a subset of T lymphocytes. Eur. J. Immunol. 12, 453-455.
13. Jenkins, M.K., 1992. The role of cell division in the induction of clonal anergy. Immunol. Today 13, 69-73.
14. Jones, L.A., Chin, L.T. and Kruisbeek, A.M. (1990) Aquisitions of self tolerance in T cells is achieved by different mechanisms, operating both inside and outside the thymus. Thymus 16, 195-206.
15. Kennedy, M.K., Tan, L.-J., Dal Canto, M.C. and Miller, S.D. (1990) Regulation of effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. J. Immunol. 145, 117-126.
16. Khoury, S.J., Akalin, E., Chandraker, A., Turka, L.A., Linsley, P.S., Sayegh M.H. and Hancock, W.W. (1995) CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J. Immunol. 155, 4521-4524.
17. Kuchroo, V.K., Das, M.P., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Ewiner, H.L., Nabavi, N. and Glimcher, L.H. (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th-1/Th-2 developmental pathways: application to autoimmune disease therapy. Cell 80, 707-718.
18. Miller, J.F.A.P. and Morahan, G. (1992) Peripheral T cell tolerance. Annu. Rev. Immunol. 10, 51-69.
19. Miller, A., Lider, O., Roberts, A., Sporn, M. and Weiner, H. (1992a) Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 89, 421-425.
20. Miller, S.D., Ian, L.J., Pope, L., McRae, B.L. and Karpus, W.J. (1992b) Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis. Inter. Rev. Immunol. 9, 203-222.
21. Mueller, D.L., Jenkins, M.K. and Schwartz, R.H. (1989) Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7, 445-480.
22. Powell, M.B., Mitchel, D., Lederman, J., Buckmeier, J., Zamvil, S.S., Graham, M., Ruddle, N. and Steinman, L. (1990) Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Intern. Immun. 2, 539-544.
23. Quill, H. and Schwartz, R.H. (1987) Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: Specific induction of a long-lived state of proliferative unresponsiveness. J. Immunol. 138, 3704-3712.
24. Raine, C.S. (1984) Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab. Invest. 43, 150-157.
25. Robinet, E., Fournel, S., Fatmi, A. and Revillard, J-P. (1996) IL-2-resistant hyporesponsiveness induced by CD4 mAbs in OKT3-activated human T cells is reversed by CD45RA triggering. Cell. Immunol. 167, 1-7.
26. Rocha, B. and von Boehmer, H. (1991) Peripheral selection of the T cell repertoire. Science 251, 1225-1228.
27. Samson, M.F. and Smilek, D.E. (1995) Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with myelin basic protein peptide analogue modified to form long-lived peptide-MCH complexes. J. Immunol. 155, 2737-2746.
28. Sette, A., Alexander, J., Ruppert, J., Snoke, K., Franco, A., Ishioka. G. and Grey, H.M. (1994) Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12, 413-431.
29. Stein, C.S., St Louis, J., Gilbert, J.J. and Strejan, G.H. (1990) Treatment of spinal cord-induced experimental allergic encephalomyelitis in the Lewis rat with liposomes presenting central nervous system antigens. J. Neuroimmunol. 28, 119-130.
30. Stevens, D.B., Gould, K.E. and Swanborg, R.H. (1994) Transforming growth factor-β1 inhibits tumor necrosis factor-α/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis. J. Neuroimmunol. 51, 77-83.
31. Steinman, L. (1991) The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease. Adv. Immunol. 49, 357-379.
32. Strejan, G.H., Gilbert, J.J. and St Louis, J. (1985) Suppression of chronic-relapsing experimental allergic enchephalomyelitis in strain-13 guinea pigs by the administration of liposome-associated myelin basic protein. J. Neuroimmunol. 7, 27-41.
33. Strejan, G.H., Gilbert, J.J. and St Louis, J. (1988) Effect of treatment with glutaraldehyde-fixed myelin basic protein-liposomes on active induction and passive transfer of experimental allergic encephalomyelitis in Lewis rats. Cell. Immunol. 116, 250-256.
34. Strejan, G.H., Percy, D.H., St. Louis, J., Surlan, D. and Paty, D.W. (1981) Suppression of experimental allergic encephalomyelitis in guinea pigs by liposome-associated human myelin basic protein. J. Immunol. 127: 2064-2069.
35. Swanborg, R.H., (1988) Experimental allergic encephalomyelitis. Meth. Enzymol. 162, 413-421.
36. Swierkosz, J. and Swanborg, R.H. (1977) Immunoregulation of Experimental Allergic Encephalomyelitis: Conditions for the induction of suppressor cells and analysis of mechanism. J. Immunol. 119, 1501-1506.
37. Traugott, U., Stone, S. and Raine, C.S. (1982) Chronic-relapsing experimental autoimmune encephalomyelitis. Treatment with combinations of myelin components promotes clinical and structural recovery. J. Neurol. Sci. 56, 65-73.
38. Vandenbark, A.A., Hashim, G. and Offner, H. (1993) TCR peptide therapy in autoimmune diseases. Intern. Rev. Immunol. 9, 251-276.
39. van der Veen, R., Trotter, J., Clark, H. and Kapp, J. (1989) The adoptive transfer of chronic-relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein. J. Neuroimmunol. 21, 183-191.
40. Wauben, M.H.M., Boog, C.J.P., vander Zee, R., Joosten, I., Schlief, A. and van Eden, W. (1992) Disease inhibition by major histocompatibility complex binding peptide analogues of disease associated epitopes: more than blocking alone. J. Exp. Med. 176, 667-677.
41. Webb, S., Morris, C. and Sprent, J. (1990) Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63, 1249-1245.
42. Weiner, H.L., Friedman, A., Miller, A., Khoury, S.J., Al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R.B., Trenthan, D.E. and Hafler, D.A. (1994) Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12, 809-837.
43. Whitacre, C.C., Gienapp, I., Orosz, C. and Bitar, D. (1991) Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J. Immunol. 147, 2155-2163.
44. Zar, J.H. (1974) Biostatistical analysis. Prentice Hall, Englewood Cliffs, New Jersey.